Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.